Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON37374Active, not recruiting
Open-label, single-arm trial of mitotane in adrenal cancer (ACC), sponsored by Máxima Medisch Centrum. Primary endpoints: Observed mitotane plasma levels, Mitotane doses administered and 2 more. Started Jun 2012; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON37374.